Format

Send to

Choose Destination
Blood Cancer J. 2018 Aug 22;8(9):81. doi: 10.1038/s41408-018-0113-4.

Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells.

Author information

1
UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Lisboa, Portugal.
2
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
3
UniversityCancerCenter (UCC) Dresden, Tumor Immunology, 'Carl Gustav Carus' Technische Universität Dresden, Dresden, Germany.
4
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), partner site Dresden, Heidelberg, Germany.
5
Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden, Germany.
6
UEIPM, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisboa, Portugal.
7
CDG & Allies, Professional and Patient Association International Network (PPAIN), Caparica, Portugal.
8
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany. M.Bachmann@hzdr.de.
9
UniversityCancerCenter (UCC) Dresden, Tumor Immunology, 'Carl Gustav Carus' Technische Universität Dresden, Dresden, Germany. M.Bachmann@hzdr.de.
10
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), partner site Dresden, Heidelberg, Germany. M.Bachmann@hzdr.de.
11
National Center of Tumor Diseases (NCT), partner site Dresden, Dresden, Germany. M.Bachmann@hzdr.de.
PMID:
30190468
PMCID:
PMC6127150
DOI:
10.1038/s41408-018-0113-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center